NUGS Stock Overview
Cannabis Strategic Ventures engages in the cultivation of marijuana products in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Cannabis Strategic Ventures Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0001 |
| 52 Week High | US$0.01 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 9,900.00% |
| 3 Month Change | 9,900.00% |
| 1 Year Change | -98.44% |
| 3 Year Change | -99.91% |
| 5 Year Change | -99.99% |
| Change since IPO | -98.40% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| NUGS | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 0.9% | 1.2% |
| 1Y | -98.4% | 13.9% | 24.7% |
Return vs Industry: NUGS underperformed the US Pharmaceuticals industry which returned 9.7% over the past year.
Return vs Market: NUGS underperformed the US Market which returned 19.3% over the past year.
Price Volatility
| NUGS volatility | |
|---|---|
| NUGS Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.9% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: NUGS's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine NUGS's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Simon Yu | www.cannabisstrategic.com |
Cannabis Strategic Ventures engages in the cultivation of marijuana products in the United States. It incubates, develops, and partners within the cannabis and ancillary sectors. The company is based in Los Angeles, California.
Cannabis Strategic Ventures Fundamentals Summary
| NUGS fundamental statistics | |
|---|---|
| Market cap | US$40.50k |
| Earnings (TTM) | -US$5.64m |
| Revenue (TTM) | US$14.60m |
0.0x
P/S Ratio0.0x
P/E RatioIs NUGS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NUGS income statement (TTM) | |
|---|---|
| Revenue | US$14.60m |
| Cost of Revenue | US$11.81m |
| Gross Profit | US$2.78m |
| Other Expenses | US$8.42m |
| Earnings | -US$5.64m |
Last Reported Earnings
Mar 31, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did NUGS perform over the long term?
See historical performance and comparison